Clinical TrialsSearch results
Number of results: 856
Recruiting
- Clinical Trial of Lurbinectedin as Single-agent or in Combination with Irinotecan Versus Topotecan or Irinotecan in Patients with Relapsed Small-cell Lung Cancer
- Relapsed Small Cell Lung Cancer
- Kobayashi Takeshi
- 2024-03-13
Recruiting
- Clinical study on the relationships between disease progression and inflammation in retinitis pigmentosa
- Retinitis pigmentosa
- Sonoda Koh-Hei
- 2021-11-09
Recruiting
- Clinical study of inguinal hernia mesh fixation with fibrin glue
- inguinal hernia
- TOMA Hiroki
- 2023-10-17
Recruiting
- Clinical research for efficacy and safety of hand-finger rehabilitation robot SMOVE for the patients with upper limb paresis after recovery stage stroke patients.
- Patients with upper limb paresis after recovery stage stroke patients.
- Mukae Nobutaka
- 2022-08-12
Recruiting
- Clinical pharmacology study to evaluate the effects of food on TAS-115 in healthy subjects
- Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype
- Motoo Yoshiharu
- 2024-07-11
Recruiting
- CATALYST Trial
- Atrial fibrillation
- Kozuma Ken
- 2022-06-09
Recruiting
- Cardiovascular event and atherosclerosis - peritoneal dialysis patients compared with hemodialysis patients.
- chronic renal failure
- Hiroshima University
- 2006-10-01
Recruiting
- CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
- -Sarcoma, Ewing -Neoplasm Metastasis
- Masaki Takeshi
- 2022-08-26
Recruiting
- Beamion LUNG 2: A Phase III, open-label, randomized, active-controlled, multi-centre trial evaluating orally administered BI 1810631 compared with standard of care as first-line treatment in patients with unresectable, locally advanced or metastatic non-squamous non-small cell lung cancer harbouring HER2 tyrosine kinase domain mutations
- Unresectable, locally advanced or metastatic non-squamous NSCLC harboring HER2 TKD mutations
- Takeuchi Yoshito
- 2023-12-04
Recruiting
- Autologous Dendritic Cell Vaccine Therapy Targeting HTLV-1 Specific Antigen for Adult T-Cell Leukemia/Lymphoma
- Adult T-Cell Leukemia/Lymphoma
- Suehiro Youko
- 2021-04-20